Clinical Trials Directory

Trials / Unknown

UnknownNCT00797121

Preoperative Biliary Drainage for Resectable Hilar Cholangiocarcinoma

Effect of Preoperative Biliary Drainage on Postoperative Complications in Resectable Patients With Hilar Cholangiocarcinoma(Klatskin Tumor)

Status
Unknown
Phase
Phase 4
Study type
Interventional
Enrollment
82 (estimated)
Sponsor
Sun Yat-sen University · Academic / Other
Sex
All
Age
18 Years – 75 Years
Healthy volunteers
Not accepted

Summary

This study is to investigate whether preoperative biliary drainage can reduce the postoperative morbidity in patients with hilar cholangiocarcinoma.

Detailed description

Preoperative biliary drainage(PBD) or not, is a Hot Spot issue in the management of Hilar cholangiocarcinoma. Surgeons from Japan tend to perform PTBD(Percutaneous Transhepatic Biliary Drainage) before a definite operation until the total bilirubin(TB) lower than 85μmol/L. For some patients needed to perform extended curative resection, PVE(Portal Vein Embolization) is performed and thus the duration of PBD may be around six weeks and the final TB is lower than 34μmol/L. Some tend to perform a definite curative operation in a short time after diagnosis. There is no RCT research on the effect of PBD for the resectable Hilar Cholangiocarcinoma patients to date.

Conditions

Interventions

TypeNameDescription
PROCEDUREPreoperative biliary drainagePercutaneous transhepatic biliary drainage(PTBD) is performed under the guidance of ultrasound. The duration may be around four weeks to make the total bilirubin of patients lower than 85μmol/L.

Timeline

Start date
2008-05-01
Primary completion
2011-05-01
Completion
2013-05-01
First posted
2008-11-25
Last updated
2008-11-25

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT00797121. Inclusion in this directory is not an endorsement.